Article Details
Retrieved on: 2025-10-02 17:37:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The San Francisco Bay Area biotech will use the funds to bring a T cell engager for colorectal cancer into the clinic. Published Oct. 2, 2025.
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here